ERBB2 and cancer: There are also antibodies on nanoparticle platforms such as Au-NPs and IO-NPs used to bind to certain receptors on the cell surface of cancer cells like HER2 and EGFR, which then carry treatment options including chemotherapy or CRISPR therapy to the cancer cells (Afzal et al., 2022).